Top Markets
Coin of the day
Mycenax Biotech Inc. Mycenax Biotech Inc.

Mycenax Biotech Inc.

4726
株式のランク #19463
Mycenax Biotech Inc. specializes in the research, development, and... Mycenax Biotech Inc. specializes in the research, development, and manufacturing of biopharmaceutical products, leveraging both mammalian and microbial cell culture systems. Its market reach extends across Taiwan, Europe, Asia, and the United States. The company cultivates a diverse portfolio of advanced biological therapeutics and components. This includes monoclonal antibodies, bi-specific antibodies, Fc-fusion proteins, recombinant proteins, peptides, non-toxic protein conjugates, antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), and single-chain variable fragments (ScFv), in addition to plasmids and DNA vaccines. Beyond product innovation, Mycenax offers a comprehensive suite of process development solutions. These encompass the establishment of production cell lines, optimization of upstream and downstream processes, industrial scale-up, formulation science, and the creation of analytical methods. The firm also provides in-house analytical testing, Good Manufacturing Practice (GMP)-compliant manufacturing services for drug substances and finished products, and cell banking, all underpinned by its specialized manufacturing technologies. Established in 2001, Mycenax Biotech Inc. is headquartered in Zhubei, Taiwan.
株価
$0.77907619
時価総額
$161.30M
変化(1日)
0.41%
変化(1年)
-37.18%
TW
取引 Mycenax Biotech Inc. (4726)

カテゴリー

Mycenax Biotech Inc.(4726)の株価履歴
終値の最高値: $0.78 (2026-08-01)

終値の最安値: $0.84 (2012-06-01)
Mycenax Biotech Inc. の株価履歴(2012 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -1.24%
2025 -23.65%
2024 15.63%
2023 -9.00%
2022 -9.14%
2021 19.68%
2020 50.73%
2019 4.22%
2018 -17.13%
2017 -12.29%
2016 -33.53%
2015 -2.54%
2014 -42.87%
2013 180.15%
2012 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.16 -12.60%
AU
$772.27 7.33%
CH